Nightingale as an investment
Financial information
Share and shareholders
Governance
- Governance principles
- General Meeting
- Annual General Meeting 2024
- Board of Directors
- Management Team
- Remuneration
- Risk management
- Insider management
- Managers' transactions
- Flagging notifications
- Auditor
- Certified Adviser
- Articles of Association
- Code of Conduct
- Stock Exchange Releases
- Company releases
- Press releases
- Managers' transactions
- Flagging notifications
- En
- Fi
Stock exchange releases
- The Finnish Financial Supervisory Authority has approved Nightingale Health Plc’s Finnish prospectus – Mar 17, 2025
- Nightingale Health establishes ADR program in the US – trading in Company’s B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US – Mar 17, 2025
- Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki – Mar 12, 2025